Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

Allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning for hematologic malignancies depends on graft-versus-tumor effects for eradication of cancer. Here, we estimated relapse risks according to disease characteristics. Between 1997 and 2006, 834 consecutive patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kahl, Christoph, Storer, Barry E., Sandmaier, Brenda M., Mielcarek, Marco, Maris, Michael B., Blume, Karl G., Niederwieser, Dietger, Chauncey, Thomas R., Forman, Stephen J., Agura, Edward, Leis, Jose F., Bruno, Benedetto, Langston, Amelia, Pulsipher, Michael A., McSweeney, Peter A., Wade, James C., Epner, Elliot, Bo Petersen, Finn, Bethge, Wolfgang A., Maloney, David G., Storb, Rainer
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2007
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1988951/
https://ncbi.nlm.nih.gov/pubmed/17595333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-03-078592
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados